| Literature DB >> 35382082 |
Shahnaz Sali1, Mitra Rezaei2,3, Majid Marjani2, Shabnam Tehrani1, Amirmohammad Abdolmohammadzadeh4, Amirali Soheili5, Davood Yadegarynia1, Sara Abolghasemi1.
Abstract
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spread widely all around the world and has infected too many healthcare workers (HCWs) as the pioneers combating coronavirus disease 2019 (COVID-19). This study aims to evaluate the symptoms and outcome of medical staff from a tertiary hospital in Tehran, Iran. Materials andEntities:
Keywords: Coronavirus; Covid-19; Healthcare workers; Medical staff; Occupational health; SARS-CoV-2
Year: 2021 PMID: 35382082 PMCID: PMC8978033
Source DB: PubMed Journal: Tanaffos ISSN: 1735-0344
Characteristics of the COVID-19 among medical personnel in general and by gender
|
|
|
| |
|---|---|---|---|
|
| 18(62.1) | 11(37.9) | 29(100) |
|
| |||
| Fever | 15(83.3) | 8(72.7) | 23(79.3) |
| Cough | 13(72.2) | 7(63.6) | 20(71.4) |
| Dyspnea | 14(77.8) | 9(81.8) | 23(79.3) |
| Diarrhea | 6(33.3) | 0(0) | 6(20.7) |
| Hyposmia | 6(33.3) | 6(54.5) | 12(41.4) |
|
| |||
| Yes | 3(16.7) | 3(27.3) | 6(20.7) |
| No | 15(83.3) | 8(72.7) | 23(79.3) |
|
| |||
| CT scan compatible | 15(83.3) | 9(81.8) | 24(82.8) |
| PCR positive | 11(61.1) | 5(45.5) | 16(55.2) |
|
| |||
| Mild to moderate | 8(44.4) | 8(72.7) | 16(55.2) |
| Severe | 8(44.4) | 3(27.3) | 11(37.9) |
| Critical | 2(11.1) | 0(0) | 2(6.9) |
|
| |||
| Physician | 8(44.4) | 1(9.1) | 9(31) |
| Nurse | 6(33.3) | 6(54.5) | 12(41.4) |
| Others | 4(22.2) | 4(36.4) | 8(27.6) |
|
| |||
| Physical examination | 9(50) | 3(27.3) | 12(41.4) |
| Giving medication to infected patients | 4(22.2) | 5(45.5) | 9(31) |
| Suction | 4(22.2) | 1(9.1) | 5(17.2) |
| Intubation | 6(33.3) | 4(36.4) | 10(34.5) |
|
| |||
| Gown/Glove/Mask | 9(50) | 5(45.5) | 14(48.3) |
| Shield | 9(50) | 4(36.4) | 13(44.8) |
| Goggle/Footwear | 8(44.4) | 4(36.4) | 12(41.4) |
|
| |||
| Long | 11(61.1) | 5(45.5) | 16(55.2) |
| Short | 7(38.9) | 6(54.5) | 13(44.8) |
|
| |||
| Hydroxychlroquine + Azithromycin | 15(83.3) | 8(72.7) | 23(79.3) |
| Lopinavir/Ritonavir | 8(44.4) | 1(9.1) | 9(31) |
| Other/None | 3(16.7) | 3(27.3) | 6(20.7) |
Abbreviations: CT: Computed tomography; PCR: Polymerase chain reaction; PPE: Personal protective equipment
Long: 15 or more days of high-risk exposure- Short: less than 15 days of exposure